Pivagabine
Pivagabine is a pharmaceutical drug that was under development for the treatment of anxiety but was discontinued. It is a pyridinyl derivative and has anxiolytic effects.
Pharmacology[edit | edit source]
Pivagabine acts as a GABA reuptake inhibitor, which means it increases the levels of the neurotransmitter GABA in the brain. GABA is the main inhibitory neurotransmitter in the brain and is involved in reducing neuronal excitability. By increasing the levels of GABA, pivagabine can reduce anxiety.
Clinical Trials[edit | edit source]
Pivagabine was tested in several clinical trials for its potential use in treating anxiety. However, the drug was discontinued and is not currently available for use.
Side Effects[edit | edit source]
Like all drugs, pivagabine has potential side effects. These can include dizziness, nausea, and fatigue. However, as the drug was discontinued, a full profile of its side effects is not available.
See Also[edit | edit source]
Pivagabine Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD